CompletedPhase 4

Dezocine for Prevention of Catheter-related Bladder Discomfort

China96 participantsStarted 2017-09-01

Plain-language summary

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Adult (\>/=18)
✓. Male or female
✓. Patients scheduled for abdominal surgery
✓. Undergoing catheterization
✓. Subject is American Society of Anesthesiologists (ASA) physical status 1 or 2

✕. Patient with bladder outflow obstruction
✕. Patient with overactive bladder (frequency greater than three times per night or more than eight times per 24 h)
✕. Patient with multisystemic diseases (central nervous system, cardiovascular system hepatic, psychiatric, and end-stage renal diseases)
✕. Patient with chemical substance abuse
✕. Patient with chronic pain
✕. Patient with morbid obesity
✕. Patient needs for urgent intervention

Catheter related bladder discomfort symptoms

Timeframe: at 1 hour after extubatio

NCT IDNCT03147066

SponsorJian-jun Yang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-10-30